Division of Infectious Diseases

High-level Review: Updated STI Guidelines Part 2

In July 2021 the Center for Disease Control and Prevention (CDC) released their sexually transmitted infections (STI) treatment guideline, an update from 2015.1 Below, senior ID fellow Dr. Jonathan Ryder highlights significant (but by no means comprehensive) changes in this new guideline that can be incorporated into clinical practice and some of the evidence supporting these changes. Part 2 – Bacterial Vaginosis, Trichomonas, Pelvic Inflammatory Disease

High-level Review: Updated STI Guidelines Part 1

In July 2021 the Center for Disease Control and Prevention (CDC) released their sexually transmitted infections (STI) treatment guideline, an update from 2015.1 Below, senior ID fellow Dr. Jonathan Ryder highlights significant (but by no means comprehensive) changes in this new guideline that can be incorporated into clinical practice and some of the evidence supporting these changes. Part 1 – Chlamydia, Gonorrhea, Mycoplasma genitalium

Ambulatory Stewardship: A Little Bit of Everything Goes a Long Way

Inappropriate outpatient antibiotic use remains a problem needing to be addressed as part of the strategy to reduce antimicrobial resistance. Jasmine Marcelin, MD and Phil Chung, PharmD led a multifaceted approach to reducing antibiotic use in ambulatory clinics within our Nebraska Medicine hospital system, recently published in Infection Control and Hospital Epidemiology.

ID Fellowship Recruiting is virtual again in 2021, and we are ready to meet you!

Fellowship application season is open and as the leaders of our ID fellowship, we wanted to highlight some of the exciting aspects of our program.  Our program and our division are growing.  We began in 2011 with 2 fellows, grew to 4 in 2017, 5 in 2020, and now our full complement is six fellows.  Our faculty also continues to grow, as we now have… Continue Reading